Our Network
Athens,
Greece
Development of oral, topical & parenteral dosage forms
Kawagoe, Japan
Production, inspection & packaging of oral solids and sterile liquids
Leipzig, Germany
Production of semi-solids and non-sterile liquids
Livron,
France
Production and packaging of sterile liquids and suppositories
Halden,
Norway
Specialized in fill & finish of ampoules and vials
Global Network
Premium Quality
Excellent Service
Global Reach, Local Expertise
Our sites in Europe and Asia present strategic locations that provide access into the major mature pharmaceutical markets.
Leverage our extensive and expanding network, led by seasoned professionals, to gain an edge both regionally and locally.
Why Partner with Us?
Quality and Customer Centricity
We ensure strict criteria is met and prioritize consistency in our service quality.
Data-Driven CDMO
Data matters! That’s why we are investing in a data-driven roadmap at Adragos Pharma to ensure that our offerings match the industry's needs.
Comprehensive Service Offerings
With our comprehensive and ever-expanding range of services at attractive locations, we are able to meet the needs of our global customers.
ESG Focus
We are committed to operating with sustainable and ethical business practices that take into account environmental impact, social responsibility and strong corporate governance.
Exciting times are ahead of us!
This is going to be great! But we can’t do it alone! Join us – we are always looking for great talent.
What's new?
Our Strategic Expansion in Japan: Reinforcing Production to 2 billion tablets and Aiming to Be the “Most Trusted CDMO”
Read about the latest news and plans of our location in Kawagoe in this article for the Yakuji Nippo newspaper. Adragos Pharma is actively pursuing
Our Global Reach: A Strategic Advantage for Clients in the Pharmaceutical Industry
In the dynamic and competitive landscape of the pharmaceutical industry, companies seek strategic partnerships that offer comprehensive solutions to streamline their processes. With a global
One of Northern Europe’s Largest Production Sites successfully taken over by the Prange Group and Adragos Pharma
Plettenberg / Munich / Halden, 1st March 2024 – The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed